CoChat

Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation

Open access
Zhang, Ji-chun, Wu, Jin, Fujita, Yuko, Yao, Wei, Ren, Qian, Yang, Chun, Li, Su-xia, Shirayama, Yukihiko, Hashimoto, Kenji · 2015 · International Journal of Neuropsychopharmacology

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), signaling represent potential therapeutic targets for major depressive disorder. The purpose of this study is to examine whether TrkB ligands show antidepressant effects in an inflammation-induced model of depression. METHODS: In this study, we examined the effects of TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) and TrkB antagonist ANA-12 on depression-like behavior and morphological changes in mice previously exposed to lipopolysaccharide (LPS). Protein levels of BDNF, phospho-TrkB (p-TrkB), and TrkB in the brain regions were also examined. RESULTS: LPS caused a reduction of BDNF in the CA3 and dentate gyrus (DG) of the hippocampus and prefrontal cortex (PFC), whereas LPS increased BDNF in the nucleus accumbens (NAc). Dexamethason suppression tests showed hyperactivity of the hypothalamic-pituitary-adrenal axis in LPS-treated mice. Intraperitoneal (i.p.) administration of 7,8-DHF showed antidepressant effects on LPS-induced depression-like behavior, and i.p. pretreatment with ANA-12 blocked its antidepressant effects. Surprisingly, ANA-12 alone showed antidepressant-like effects on LPS-induced depression-like behavior. Furthermore, bilateral infusion of ANA-12 into the NAc showed antidepressant effects. Moreover, LPS caused a reduction of spine density in the CA3, DG, and PFC, whereas LPS increased spine density in the NAc. Interestingly, 7,8-DHF significantly attenuated LPS-induced reduction of p-TrkB and spine densities in the CA3, DG, and PFC, whereas ANA-12 significantly attenuated LPS-induced increases of p-TrkB and spine density in the NAc. CONCLUSIONS: The results suggest that LPS-induced inflammation may cause depression-like behavior by altering BDNF and spine density in the CA3, DG, PFC, and NAc, which may be involved in the antidepressant effects of 7,8-DHF and ANA-12, respectively.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ijnp/pyu077

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. BDNF protein in the brains of control and LPS-treated mice. (A): The schedule of treatment. (B): Brain regions (CA1, CA3, DG, PFC, NAc) for Western blot analysis of BDNF. (C): Western blot analysis of BDNF in the CA1, CA3, and DG of the hippocampus, the PFC, and the NAc. The value was expressed as a percentage of that of saline-treated mice. Values represent the mean ± standard error of the mean (SEM; n = 6). *p < 0.05 compared with saline treated groups (student’s t-test). (D and E): Dexamethasome (DEX) suppression test. (D): The schedule of treatment. (E): Blood sample was collected 6 hours after injection of DEX, and serum corticosterone was measured by ELISA. Data represent mean ± SEM (n = 11–12 mice per group). *p < 0.05 compared with saline-treated groups (student’s t-test). LPS: lipopolysaccharide; DG: dentate gyrus; PFC: prefrontal cortex; NAc: nucleus accumbens.
Figure 1. BDNF protein in the brains of control and LPS-treated mice. (A): The schedule of treatment. (B): Brain regions (CA1, CA3, DG, PFC, NAc) for Western blot analysis of BDNF. (C): Western blot analysis of BDNF in the CA1, CA3, and DG of the hippocampus, the PFC, and the NAc. The value was expressed as a percentage of that of saline-treated mice. Values represent the mean ± standard error of the mean (SEM; n = 6). *p < 0.05 compared with saline treated groups (student’s t-test). (D and E): Dexamethasome (DEX) suppression test. (D): The schedule of treatment. (E): Blood sample was collected 6 hours after injection of DEX, and serum corticosterone was measured by ELISA. Data represent mean ± SEM (n = 11–12 mice per group). *p < 0.05 compared with saline-treated groups (student’s t-test). LPS: lipopolysaccharide; DG: dentate gyrus; PFC: prefrontal cortex; NAc: nucleus accumbens.CC BY · PubMed Central
Figure 2. Effects of 7,8-DHF and 5,7-DHF on LPS-induced depression-like behavior. (A) The schedule of treatment and behavioral evaluations. (B) Locomotion, (C) TST, and (D) FST tests. Values represent the mean ± standard error of the mean (n = 8–11). *p < 0.05, **p < 0.01, ***p < 0.001 compared with the vehicle + LPS group. N.S.: not significant. 7,8-DHF: 7,8-dihydroxyflavone; 5,7-DHF: 5,7-dihydroxyflavone; LPS: lipopolysaccharide; TST: tail suspension test; FST: forced swimming test.
Figure 2. Effects of 7,8-DHF and 5,7-DHF on LPS-induced depression-like behavior. (A) The schedule of treatment and behavioral evaluations. (B) Locomotion, (C) TST, and (D) FST tests. Values represent the mean ± standard error of the mean (n = 8–11). *p < 0.05, **p < 0.01, ***p < 0.001 compared with the vehicle + LPS group. N.S.: not significant. 7,8-DHF: 7,8-dihydroxyflavone; 5,7-DHF: 5,7-dihydroxyflavone; LPS: lipopolysaccharide; TST: tail suspension test; FST: forced swimming test.CC BY · PubMed Central
Figure 3. Role of TrkB and mTORC1 in the antidepressant action of 7,8-DHF and ANA-12 on LPS-induced depression-like behavior. (A–C) The schedule of treatment and behavioral evaluations. (D) Locomotion, (E) TST, and (F) FST tests. Values represent the mean ± standard error of the mean (SEM). n = 8–10 for D, E, and F. **p < 0.01, ***p < 0.001 compared with the LPS + vehicle group. ## p < 0.01 compared with the LPS + 7,8-DHF + ANA-12 group. N.S.: not significant. (G) TST and (H) FST. Bilateral infusion of ANA-12 into the NAc significantly attenuated the increase of immobility time of LPS-treated mice. Values represent the mean ± SEM. n = 7 for (G) and (H). *p < 0.05, **p < 0.01 compared with the LPS + vehicle group. (I): TST, (J): FST. I.c.v. infusion of rapamycin significantly blocked the decrease of immobility time of LPS-treated mice by 7,8-DHF. In contrast, i.c.v. infusion of rapamycin did not affect the decrease of immobility time of LPS-treated mice by ANA-12. Values represent the mean ± SEM (n = 8 – 10). **p < 0.01, ***p < 0.001 compared with the LPS + vehicle group. ## p < 0.01 compared with the LPS + 7,8-DHF group. N.S.: not significant. TrkB: tropomyosin-receptor-kinase B; mTORC1: mammalian target of rapamycin complex 1; 7,8-DHF:7,8-dihydroxyflavone; TST: tail suspension test; FST: forced swimming test; NAc: nucleus accumbens; i.c.v.: intracerebroventricular.
Figure 3. Role of TrkB and mTORC1 in the antidepressant action of 7,8-DHF and ANA-12 on LPS-induced depression-like behavior. (A–C) The schedule of treatment and behavioral evaluations. (D) Locomotion, (E) TST, and (F) FST tests. Values represent the mean ± standard error of the mean (SEM). n = 8–10 for D, E, and F. **p < 0.01, ***p < 0.001 compared with the LPS + vehicle group. ## p < 0.01 compared with the LPS + 7,8-DHF + ANA-12 group. N.S.: not significant. (G) TST and (H) FST. Bilateral infusion of ANA-12 into the NAc significantly attenuated the increase of immobility time of LPS-treated mice. Values represent the mean ± SEM. n = 7 for (G) and (H). *p < 0.05, **p < 0.01 compared with the LPS + vehicle group. (I): TST, (J): FST. I.c.v. infusion of rapamycin significantly blocked the decrease of immobility time of LPS-treated mice by 7,8-DHF. In contrast, i.c.v. infusion of rapamycin did not affect the decrease of immobility time of LPS-treated mice by ANA-12. Values represent the mean ± SEM (n = 8 – 10). **p < 0.01, ***p < 0.001 compared with the LPS + vehicle group. ## p < 0.01 compared with the LPS + 7,8-DHF group. N.S.: not significant. TrkB: tropomyosin-receptor-kinase B; mTORC1: mammalian target of rapamycin complex 1; 7,8-DHF:7,8-dihydroxyflavone; TST: tail suspension test; FST: forced swimming test; NAc: nucleus accumbens; i.c.v.: intracerebroventricular.CC BY · PubMed Central
Figure 4. Effects of 7,8-DHF and ANA-12 on LPS-induced changes in phosphorylation of TrkB in the mouse brain. (A): The schedule of treatment. (B): Western blot of p-TrkB protein in the mouse brain. (C): Western blot of total TrkB protein in the mouse brain. The value was expressed as a percentage of that of saline-treated mice. Values represent the mean ± standard error of the mean (n = 5–6). *p < 0.05, **p < 0.01, as compared with the LPS + vehicle group. # p < 0.05, ## p < 0.01 as compared with the LPS + 7,8-DHF group. N.S.: not significant. 7,8-DHF: 7,8-dihydroxyflavone; LPS: lipopolysaccharide; TrkB: tropomyosin-receptor-kinase B; p-TrkB: phospho-TrkB.
Figure 4. Effects of 7,8-DHF and ANA-12 on LPS-induced changes in phosphorylation of TrkB in the mouse brain. (A): The schedule of treatment. (B): Western blot of p-TrkB protein in the mouse brain. (C): Western blot of total TrkB protein in the mouse brain. The value was expressed as a percentage of that of saline-treated mice. Values represent the mean ± standard error of the mean (n = 5–6). *p < 0.05, **p < 0.01, as compared with the LPS + vehicle group. # p < 0.05, ## p < 0.01 as compared with the LPS + 7,8-DHF group. N.S.: not significant. 7,8-DHF: 7,8-dihydroxyflavone; LPS: lipopolysaccharide; TrkB: tropomyosin-receptor-kinase B; p-TrkB: phospho-TrkB.CC BY · PubMed Central
Figure 5. Effects of 7,8-DHF and ANA-12 on LPS-induced changes in spine density within mouse brain. (A): The schedule of treatment. (B): Representative photomicrographs of Golgi-Cox stained pyramidal neurons in the CA1, CA3, and DG of the hippocampus from animals of each group. Scale bar = 10 µm. (C): Values represent the mean ± standard error of the mean (SEM; n = 6). (D): Representative photomicrographs of Golgi-Cox stained pyramidal neurons in the PFC from animals of each group. Scale bar = 10 µm. (F): Values represent the mean ± SEM (n = 6). (E): Representative photomicrographs of Golgi-Cox stained pyramidal neurons in the NAc-shell and NAc-core from animals of each group. Scale bar = 10 µm. (G): Values represent the mean ± SEM (n = 6). *p < 0.05,**p < 0.01, ***p < 0.001 as compared with the LPS + vehicle group. 7,8-DHF: 7,8-dihydroxyflavone; LPS: lipopolysaccharide; DG: dentate gyrus; PFC: prefrontal cortex; NAc: nucleus accumbens.
Figure 5. Effects of 7,8-DHF and ANA-12 on LPS-induced changes in spine density within mouse brain. (A): The schedule of treatment. (B): Representative photomicrographs of Golgi-Cox stained pyramidal neurons in the CA1, CA3, and DG of the hippocampus from animals of each group. Scale bar = 10 µm. (C): Values represent the mean ± standard error of the mean (SEM; n = 6). (D): Representative photomicrographs of Golgi-Cox stained pyramidal neurons in the PFC from animals of each group. Scale bar = 10 µm. (F): Values represent the mean ± SEM (n = 6). (E): Representative photomicrographs of Golgi-Cox stained pyramidal neurons in the NAc-shell and NAc-core from animals of each group. Scale bar = 10 µm. (G): Values represent the mean ± SEM (n = 6). *p < 0.05,**p < 0.01, ***p < 0.001 as compared with the LPS + vehicle group. 7,8-DHF: 7,8-dihydroxyflavone; LPS: lipopolysaccharide; DG: dentate gyrus; PFC: prefrontal cortex; NAc: nucleus accumbens.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Cited by

See all 303

Metadata

Authors
Zhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K.
Affiliations
Chiba University (JP)
Corresponding author
Hashimoto, Kenji
Venue
International Journal of Neuropsychopharmacology
Published
2015-01-26
Volume
18
Issue
4
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2055018912
Cited by
289
References
72
Citations by year
2026: 6 · 2025: 14 · 2024: 18 · 2023: 23 · 2022: 26 · 2021: 46 · 2020: 17 · 2019: 24 · 2018: 33 · 2017: 25 · 2016: 37 · 2015: 18
FWCI
27.18
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Eli Lilly and Company
  • Ministry of Education, Culture, Sports, Science and Technology (24116006)
  • Astellas Pharma
  • Chiba University
  • SENSHIN Medical Research Foundation
  • Japan Society for the Promotion of Science (24116006)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
TrkB signaling, brain-derived neurotrophic factor, antidepressant effects, depression-like behavior, lipopolysaccharide-induced inflammation, 7,8-dihydroxyflavone, ANA-12, dendritic spine density, hippocampus, prefrontal cortex, nucleus accumbens, hypothalamic-pituitary-adrenal axis, major depressive disorder
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Animals, Antidepressive Agents, Azepines, Benzamides, Depressive Disorder, Disease Models, Animal, Hippocampus, Lipopolysaccharides, Male, Mice, Inbred C57BL, Nucleus Accumbens, Phosphorylation, Prefrontal Cortex, Brain-Derived Neurotrophic Factor, Receptor, trkB, Multiprotein Complexes, Flavones, Dendritic Spines, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation. https://app.cochat.ai/papers/10.1093/ijnp/pyu077
The paper
Zhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K. (2015). Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyu077

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.